Visits: 1508, Avg visit time (secs): 262,29 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 682 | 45,23% | |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 129 | 8,55% |
| /recipients.html | 55 | 3,65% |
| /efsd-grant/efsd-clinres-recipients.html | 40 | 2,65% |
| /medtronic/efsd-medtronic-recipients.html | 36 | 2,39% |
| /msd/efsd-msd-recipients.html | 35 | 2,32% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 32 | 2,12% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 32 | 2,12% |
| /gsk/efsd-gsk-recipients.html | 29 | 1,92% |
| /novo-t1/efsd-novo-t1-recipients.html | 24 | 1,59% |
| /amylin/efsd-amylin-recipients.html | 24 | 1,59% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 689 | 45,69% |
| /efsd-grant/efsd-clinres-recipients.html | 149 | 9,88% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 57 | 3,78% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 56 | 3,71% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 42 | 2,79% |
| /gsk/efsd-gsk-recipients.html | 36 | 2,39% |
| /lilly/efsd-lilly-recipients.html | 32 | 2,12% |
| /home.html | 24 | 1,59% |
| /novo-t1/efsd-novo-t1-recipients.html | 24 | 1,59% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 22 | 1,46% |
| /msd/efsd-msd-recipients.html | 21 | 1,39% |